The National Drug and Alcohol Research Centre completed one of the first studies to examine the efficacy of an integrated exposure-based therapy for co-occurring substance use disorder and post traumatic stress disorder (PTSD). This study lead to the development the Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) Program, a cognitive-behavioral psychotherapy program designed for patients who have posttraumatic stress disorder (PTSD) and a co-occurring alcohol or drug use disorder. COPE represents an integration of two evidence-based treatments: Prolonged Exposure (PE) therapy for PTSD and Relapse Prevention for substance use disorders.
COPE is an integrated treatment, meaning that both the PTSD and substance use disorder are addressed concurrently in therapy by the same clinician, and patients can experience substantial reductions in both PTSD symptoms and substance use severity. Patients use the COPE Patient Workbook while their clinician uses the Therapist Guide to deliver treatment. The Therapist Guide is designed for clinicians on the front-line in commuity-based settings, as well as academic, hospital, and private practice settings.
The Therapist Guide and Patient Workbook are now available.